Changes over time in real-world next-generation sequencing (NGS) test use in patients (pts) with advanced non-small cell lung cancer (aNSCLC).

被引：0
|
作者：
Swaminathan, Akshay [1 ]
Stergiopoulos, Stella [2 ]
Snider, Jeremy [1 ]
Fisher, Virginia [2 ]
Castellanos, Emily [1 ]
Snow, Tamara [1 ]
Cho-Phan, Cheryl [1 ]
Comment, Leah [2 ]
Cunningham, Rachel [2 ]
McCusker, Margaret E. [1 ]
机构：
[1] Flatiron Hlth, New York, NY USA
[2] Fdn Med, Cambridge, MA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
864
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical impact of plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC)
    Bonanno, L.
    Pavan, A.
    Ferro, A.
    Calvetti, L.
    Frega, S.
    Pasello, G.
    Aprile, G.
    Guarneri, V.
    Conte, P. F.
    ANNALS OF ONCOLOGY, 2019, 30 : 577 - 577
  • [2] Real-world treatment sequencing in advanced non-small cell lung cancer (aNSCLC).
    Radtchenko, Janna
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Circulating tumour (ct) DNA next generation sequencing (NGS) in UK advanced non-small cell lung cancer (aNSCLC) patients (pts)
    Cui, W.
    Milner-Watts, C.
    Lyons, H.
    Yousaf, N.
    Minchom, A. R.
    Bhosle, J.
    Davidson, M.
    Scott, S.
    Faull, I.
    Nagy, R. J.
    O'Brien, M. E. R.
    Popat, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S787 - S788
  • [4] Brain metastases (BM) and next-generation sequencing (NGS) timing: Real-world (RW) outcomes for patients (pts) with advanced non-small cell lung cancer (aNSCLC) and MET exon 14 skipping mutations (METex14)
    Le, Xiuning
    Robb, Stephen
    Caro, Nydia
    Doria, Simona
    Rhodes, Whitney C.
    Wu, Wen-Hsing
    Kim, Julia
    Pretre, Vincent
    Ye, Fen
    CANCER RESEARCH, 2022, 82 (12)
  • [5] MET Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting
    Schubart, Christoph
    Stoehr, Robert
    Toegel, Lars
    Fuchs, Florian
    Sirbu, Horia
    Seitz, Gerhard
    Seggewiss-Bernhardt, Ruth
    Leistner, Rumo
    Sterlacci, William
    Vieth, Michael
    Seidl, Christoph
    Mugler, Michael
    Kapp, Markus
    Hohenforst-Schmidt, Wolfgang
    Hartmann, Arndt
    Haller, Florian
    Erber, Ramona
    CANCERS, 2021, 13 (19)
  • [6] The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China
    Zhang, Yan
    Shen, Wen-Xiang
    Zhou, Li-Na
    Tang, Min
    Tan, Yue
    Feng, Chun-Xia
    Li, Ping
    Wang, Li-Qiang
    Chen, Min-Bin
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [7] Real-World Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC) in the US
    Nadler, E.
    Chang, J.
    Zhang, X.
    Aguilar, K.
    Zhou, J.
    Arondekar, B.
    Pawar, V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S38 - S39
  • [8] Analysis of real-world data (RWD) on treatment (tx) sequencing in patients with advanced non-small cell lung cancer (aNSCLC).
    Ma, Meng
    Zhou, Xiang
    Goldsweig, Howard
    Hahner, Nicholas
    Han, Dianwei
    Dietz, Matthew
    Jones, Scott
    Mullaney, Tommy
    Redfern, Arielle
    Jappe, Whitney
    Liu, Zongzhi
    Yadav, Kamlesh
    Zimmerman, Michelle
    Prentice, Tony
    Pan, Qi
    Hirsch, Fred R.
    Oh, William K.
    Schadt, Eric E.
    Li, Dan
    Chen, Rong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Real-world characterization of advanced/metastatic non-small cell lung cancer (aNSCLC) patients (pts) with rapid disease progression (RDP).
    Gutierrez, Martin
    Molife, Cliff
    Belli, Andrew J.
    Hansen, Eric
    Stefaniak, Victoria Jennifer
    Winfree, Katherine B.
    Cui, Zhanglin Lin
    Batus, Marta
    Clarke, Jeffrey Melson
    Narayanan, Viraj
    Manion, Chelsea
    Norden, Andrew David
    Bonomi, Philip D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Practice- and provider-level inequities in next-generation sequencing (NGS) testing by race/ethnicity for patients (pts) with advanced non-small cell lung cancer (aNSCLC) treated in the community setting
    Vidal, Gregory A.
    Jain, Neha
    Fisher, Aaron
    Sheinson, Daniel
    Lofgren, Katherine T.
    Ma, Esprit
    Yu, Elaine
    Comment, Leah
    Miksad, Rebecca A.
    Daniel, Davey B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345